Peter Horby is Professor of Emerging Infectious Diseases and Global Health. He is the former, and founding Director of the Oxford University Clinical Research Unit in Hanoi, Vietnam. Established in early 2006, the unit conducts research on infectious diseases which crosses the disciplines of basic science, medical science and public health.
Peter returned to Oxford in July 2014 and established the Epidemic diseases Research Group Oxford (ERGO). ERGO is engaged in an international program of clinical and epidemiological research to prepare for and respond to emerging infections that may develop into epidemics or pandemics. ERGO is involved in a number of international projects including the European Commission funded PREPARE project, and the International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC). The group is conducting research on a range of epidemic diseases including Ebola virus disease, bird flu (H5N1 and H7N9), MERS-CoV, and Enterovirus 71. ERGO currently comprises a team of eight people under the leadership of Professor Peter Horby and is funded by the Wellcome Trust, the Medical Research Council, and the European Commission.
In June 2016, Peter became Chair of ISARIC, taking over from outgoing Chair Abdullah Brooks.
SALAM AP, ROJEK A, DUNNING J, HORBY PW. CLINICAL TRIALS OF THERAPEUTICS FOR THE PREVENTION OF CONGENITAL ZIKA VIRUS DISEASE: CHALLENGES AND POTENTIAL SOLUTIONS
Ann Intern Med. 2017 Mar 21. doi: 10.7326/M16-2530. [Epub ahead of print] Read Abstract | Read More
WHITEHEAD J, HORBY P. GOST: A GENERIC ORDINAL SEQUENTIAL TRIAL DESIGN FOR A TREATMENT TRIAL IN AN EMERGING PANDEMIC
PLoS Negl Trop Dis. 2017 Mar 9;11(3):e0005439. doi: 10.1371/journal.pntd.0005439. eCollection 2017 Mar 9. Read Abstract | Read More
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 82:126-132 Sep 2016 (Journal article) Read Abstract
The Pediatric infectious disease journal 35(10):e285-e300 Oct 2016 (Journal article) Read Abstract
The Lancet. Infectious diseases 16(7):e108-e118 Jul 2016 (Journal article) Read Abstract
TEACHING RESEARCH METHODOLOGY WITHIN AN EBOLA VIRUS OUTBREAK
Journal of virology 90(14):6549-6556 Jul 2016 (Journal article) Read Abstract
HORBY PW, ROJEK A. 2016. MODERNISING EPIDEMIC SCIENCE: ENABLING PATIENT-CENTRED RESEARCH DURING EPIDEMICS.
BMC Medicine. 2016:14:12. DOI: 10.1186/s12916-016-0760-x Read Abstract
DUNNING J, SAHR F, ROJEK A, GANNON F, CARSON G, IDRISS B, MASSAQUOI T, GANDI R, JOSEPH S, OSMAN HK, BROOKS TJ, SIMPSON AJ, GOODFELLOW I, THORNE L, ARIAS A, MERSON L, CASTLE L, HOWELL-JONES R, PARDINAZ-SOLIS R, HOPE-GILL B, FERRI M, GROVE J, KOWALSKI M, STEPNIEWSKA K, LANG T, WHITEHEAD J, OLLIARO P, SAMAI M, HORBY PW; RAPIDE-TKM TRIAL TEAM. 2016. Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial. PLoS Med. 2016 Apr 19;13(4):e1001997. doi: 10.1371/journal.pmed.1001997. Read Abstract
HOPE-GILL B, IDRISS B, MASSAQUOI T, HORBY P. 2016. Teaching research methodology within an Ebola virus outbreak. Med Educ. 2016 May;50(5):584-5. doi: 10.1111/medu.13033. No abstract available.
WHITEHEAD J, OLLIARO P, LANG T, HORBY P. 2016. Trial design for evaluating novel treatments during an outbreak of an infectious disease. Clin Trials. 2016 Feb;13(1):31-8. doi: 10.1177/1740774515617740. Epub 2016. Read Abstract | Read more
Lancet, 371 (9622), pp. 1392-1394. | Read more2008. Person-to-person transmission of influenza A (H5N1).